Skip to main content
OpenTrials
Completed

NCT Number: NCT06646003

Reference Values and Determinants of 6-minute Walk Test

The first aim of this study was to investigate the reference values of 6-minute walk test (6MWT) distance in patients with chronic stroke. The second aim was to determine the factors predicting 6MWT distance in patients with chronic stroke.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Ankara Gaziler Physical Medicine and Rehabilitation Education and Research Hospital

Ankara, Turkey (Türkiye)

About this study

There may be large variations in the distance of 6MWT according to the stroke severity. Investigation of factors related to 6MWT may be helpful in determining and targeting appropriate strategies for gait rehabilitation. Accordingly, the first aim of this study was to investigate the reference values of 6-minute walk test (6MWT) distance in patients with chronic stroke. The second aim was to determine the factors predicting 6MWT distance in patients with chronic stroke.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Having first ever stroke
  • The time elapsed after the stroke is more than 6 months and less than 10 years
  • 18-80 years old
  • Those who could walk independently with no assistance or device and who could walk with an intermittent or continuous light touch to assist balance or coordination

Exclusion criteria

Exclusion criteria

  • A history of severe musculoskeletal, cardiopulmonary, or psychiatric disease that can inhibit measurements
  • Patients who had received a neurologic diagnosis other than stroke, such as Parkinson's disease or multiple sclerosis
  • Patients with impaired level of consciousness and evidence of gross cognitive impairment (Scored below 10 points in the Mini-Mental State Examination

Treatment and study plan

Evaluation of 6-minute walking distance and related factors in patients with chronic stroke

Other

Evaluation of 6-minute walking distance and related factors in patients with chronic stroke.

Primary outcomes

  1. 6-minute walk test (6MWT)

    Time frame: through study completion, an average of one month

    6MWT will be used to evaluate the walking endurance. A 30-m indoor walkway will be used to conduct the test. The maximal distance covered at the end of the 6MWT will be recorded.

Secondary outcomes

  1. Functional ambulation scale (FAC)

    Time frame: through study completion, an average of one month

    Patients will be classified by walking ability using FAC has six levels (0 to 5) that are classified according to the walking ability on the basis of the amount of physical support required, which are as follows: nonfunctional ambulatory(FAC 0); ambulatory, continuous manual contact to support body weight as well as to maintain balance or to assist coordination (FAC 1); ambulatory [level I], intermittent or continuous light touch to assist balance or coordination (FAC 2); ambulatory, dependent on supervision (FAC 3); ambulatory, independent, level surface only (FAC 4); and ambulatory, independent (FAC 5).

  2. Brunnstrom motor recovery staging

    Time frame: through study completion, an average of one month

    Upper extremity, hand and lower extremity motor recovery will be assessed using the Brunnstrom 6 sequential stages of motor recovery.

  3. Modified Ashworth Scale (MAS)

    Time frame: through study completion, an average of one month

    The Modified Ashworth Scale will be used to measure the severity of knee extensor, knee flexor and ankle plantar flexor spasticity. MAS scores will be added together to give a total MAS score. MAS is graded from 0 to 4. A score of 0 indicates no increase at all in muscle tone, and 4 indicates that the joint is rigid in flexion or extension.

  4. Beck depression inventory (BDI)

    Time frame: through study completion, an average of one month

    The beck depression inventory (BDI) will be used to evaluate depression. The BDI consists of 21 questions about how the subject has been feeling in the last week. Each question has a set of at least four possible answers, ranging in intensity. A value of 0-3 is assigned for each answer, and the total score is compared with a key to determine the severity of depression .The standard cut off values are as follows: 0-9, minimal depression; 10-18, mild depression; 19-29, moderate depression; and 30-63, severe depression.

  5. Mini-mental state examination (MMSE)

    Time frame: through study completion, an average of one month

    The mini-mental state examination will be used to describe mental and cognitive functions.

  6. Star cancellation test

    Time frame: through study completion, an average of one month

    Star cancellation test will be used to describe neglect phenomenon.

  7. Barthel Index

    Time frame: through study completion, an average of one month

    Activities of daily living (ADL) will be assessed using the Barthel Index. The Barthel Index consists of 10 items that measure a person's daily functioning, specifically ADL and mobility. The items include feeding, bathing, grooming, dressing, toileting, transferring, walking on a level surface, going up and down stairs, and continence of bowel and bladder. A patient with a maximum score of 100 points is defined as continent, able to eat and dress independently, able to walk at least a block, and able to go up and down stairs.

  8. Berg Balance Scale (BBS)

    Time frame: through study completion, an average of one month

    Balance ability will be tested using the Berg Balance Scale (BBS), which includes 14 functional balance items, with scores ranging from 0 to 56 points; better balance is indicated by a higher score.

Sponsors and collaborators

Lead sponsor

Gaziler Physical Medicine and Rehabilitation Education and Research Hospital

Other

Registry information

Official study title

Reference Values and Determinants of 6-minute Walk Test Distance in Turkish Patients With Chronic Stroke: A Multicenter Cross-sectional Study

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Oct 17, 2024
Registry last updated
Dec 5, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.